Showing results (131-140 of 176) with videos related to
Sort By:
Pageof 18
Transplantation|May 8, 2000
Lamivudine for hepatitis B in liver transplantation: a single-center experienceG Malkan, M S Cattral, A Humar, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2013
Randomized controlled trial of high-dose intradermal versus standard-dose intramuscular influenza vaccine in organ transplant recipientsA Baluch, A Humar, D Eurich, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 6, 2009
An assessment of herpesvirus co-infections in patients with CMV disease: correlation with clinical and virologic outcomesA Humar, A Asberg, D Kumar, et al.Clinical Transplantation|December 31, 1997
Effect of initial slow graft function on renal allograft rejection and survivalA Humar, E M Johnson, W D Payne, et al.Surgery|April 4, 1998
The acutely ischemic extremity after kidney transplant: an approach to managementA Humar, E M Johnson, W D Payne, et al.Transplantation|November 26, 1999
Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipientsA Humar, D Gregson, A M Caliendo, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 23, 2009
Selective retransplant after graft loss to nonadherence: success with a second chanceT B Dunn, B J Browne, K J Gillingham, et al.British Journal of Anaesthesia|December 17, 2011
Pulmonary thromboembolism during adult liver transplantation: incidence, clinical presentation, outcome, risk factors, and diagnostic predictorsT Sakai, T Matsusaki, F Dai, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 21, 2007
Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipientsA Asberg, A Humar, H Rollag, et al.Scientific Reports|September 2, 2017
Impact of Immunosuppression on the Metagenomic Composition of the Intestinal Microbiome: a Systems Biology Approach to Post-Transplant DiabetesM Bhat, E Pasini, J Copeland, et al.Pageof 18